For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

GLP-1 / Metabolic

MOTS-c

Also known as: Mitochondrial Open reading frame of the Twelve S rRNA type-c

MOTS-c is an investigational mitochondrial-derived peptide studied preclinically for metabolic regulation. It is research-only and not FDA-approved; the CB4211 analog program (CohBar) was discontinued in 2023.

Where to buy · live market data

Who's worth your money for MOTS-c

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (99) of 38 scored sellers

$2.30/mg

$45.99 · 20mg · 99.9% purity

11 COAs
Buy code MERIT · 10% off

Best value

Lowest $/mg among scored sellers

$0.00/mg

— · 10mg · 99.8% purity

Most tested

9 independent COAs on file

$11.00/mg

$110 · 10mg · 99.8% purity

9 COAs
Buy code MERIT · 15% off

Average price

$4.39/mg

Sellers

92

45-day trend

-9.2%

78 of 92 sellers have a current price· 28 stale hidden· 12 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch MOTS-c

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About MOTS-c

CAS

1627580-64-6

Molecular formula

C101H152N28O22S2

Sequence

MRWQEMGYIFYPRKLR

Typical dose range

5–10 mg subcutaneous, 2–3 times per week (research use)

Half-life

~4–6 hours (estimated; exercise-induced endogenous levels return to baseline within ~4 hours)

Independent evidence

COAs for MOTS-c

322 third-party tests across 53 vendors. Each card links to the full report.

All 322 COAs for MOTS-c →
Measured purity 66.5%–100.0% across 212 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.33 %
Jul 2026
Janoshik Analytical Limited

For

MOTS-C

by Verified Peptides· batch M007261420M

Aggregated · 3rd-party listing
99.55 %
Jul 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Peptide Plugs· batch 160-04-DK

Aggregated · 3rd-party listing
99.54 %
Jul 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Rescue Research USA· batch RR-MS-2607

Aggregated · 3rd-party listing
99.91 %
Jul 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Peptide Plugs· batch 149-01-DK

Aggregated · 3rd-party listing
99.83 %
Jul 2026
Chromate Moderate

For

MOTS-c

by Arcane Peptides· batch MOT002

Aggregated · 3rd-party listing
99.83 %
Jul 2026
Chromate Moderate

For

MOTS-c

by Moglabs· batch MOT002

✓ Vendor-published
99.83 %
Jul 2026
Chromate Moderate

For

MOTS-c

by Ruo Bio· batch MOT002

COA on file
✓ Vendor-published
99.83 %
Jul 2026
MogLabs.bio

For

MOTS-c

by Moglabs· batch MOT002

COA on file
✓ Vendor-published
99.69 %
Jul 2026
Chromate Moderate

For

MOTS-c

by Ruo Bio· batch MOT402

COA on file
Aggregated · 3rd-party listing
87.17 %
Jun 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Nova Peptides· batch NV-P-O9NB

Aggregated · 3rd-party listing
99.88 %
Jun 2026
Accumark Labs

For

MOTS-c

by Polaris Peptides· batch POL-M10-8

Aggregated · 3rd-party listing
99.86 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by NG Peptide· batch MS40-08

Aggregated · 3rd-party listing
99.66 %
Jun 2026
Accumark Labs

For

MOTS-c

by Peptide Crafters· batch PC-G3-MOT15

Aggregated · 3rd-party listing
99.20 %
Jun 2026
Arrow Lab Solutions

For

MOTS-c

by Real Peptides· batch RP062326MC

Aggregated · 3rd-party listing
99.33 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Sunrise Bioresearch· batch MTC10MAY26-02

✓ Vendor-published
99.33 %
Jun 2026
ILS Laboratories

For

MOTS-C

by Sunrise Bioresearch· batch MTC10MAY26-02

COA on file
Aggregated · 3rd-party listing
99.48 %
Jun 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Apexx Biolabs· batch Light Purple Cap-1

Aggregated · 3rd-party listing
99.35 %
Jun 2026
Kovera Labs

For

MOTS-c

by Real Peptides· batch BATCH-0322

Aggregated · 3rd-party listing
99.00 %
Jun 2026
Ethos Analytics Strong

For

MOTS-C

by OROS Research· batch OR-LPMOTS10-626-B8

Aggregated · 3rd-party listing
99.56 %
Jun 2026
Freedom Diagnostics Moderate

For

MOTS-C

by Rescue Research USA· batch WP-MS-2606

Aggregated · 3rd-party listing
99.48 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Ion Peptide· batch MC40-06032026

✓ Vendor-published
99.48 %
Jun 2026
ILS Laboratories

For

MOTS-C

by Ion Peptide· batch MCD4-06022026

COA on file
✓ Vendor-published
99.66 %
Jun 2026
MZ Biolabs Moderate

For

MOTS-C

by Sports Technology Labs· batch 2026-06-30

COA on file
Aggregated · 3rd-party listing
99.51 %
Jun 2026
ILS Labs Strong

For

MOTS-C

by Peptide Plugs· batch 127-02-DK

Research depth

23 citations indexed for MOTS-c

All research on MOTS-c →

cohort · 2027

Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding

This study investigates how different types of fasting affect cell health, specifically focusing on how mitochondria (the energy-producing parts of cells) are cleared and renewed.

review · 2026

MOTS-c in sepsis-induced cardiomyopathy: Mechanisms and translational potential

Sepsis-induced cardiomyopathy (SICM) is a prevalent cardiac complication of sepsis that is characterized by inflammatory dysregulation, mitochondrial dysfunction, metabolic disturbance, and changes in the myocardial microenvironment.

Study · 2026

MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide

The mitochondrial DNA (mtDNA) can trigger immune responses and directly entrap pathogens, but it is not known to encode active immune factors. The immune system is traditionally thought to be exclusively nuclear-encoded.

Study · 2026

Are serum MOTS-c levels and MOTS-c m.1382A>C polymorphism related to polycystic ovary syndrome?

Objective MOTS-c is a mitochondria-derived peptide associated with reduced insulin resistance and obesity. The m.1382A>C polymorphism of the MOTS-c gene is linked to an increased risk of type 2 diabetes in men.

animal · 2026

MOTS-c partially protects against skeletal muscle deterioration in C26 cachexia

Background Cancer cachexia is a multifactorial metabolic syndrome marked by progressive skeletal muscle loss, reduced function, and increased mortality. Mitochondrial dysfunction is a key driver of this phenotype.

Study · 2026

Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

Background: Atrial fibrillation (AF) is a common clinical arrhythmia associated with mitochondrial dysfunction, oxidative stress, and atrial fibrosis. Mitochondrial-derived peptides (MDPs), including humanin (HN) and MOTS-c, exhibit cytoprotective properties, but their role in AF remains largely unknown.